ADR-AC GmbH, Bern launches a laboratory analysis test service for memory T cells against the novel 2019 Coronavirus

Call for entries 2021 marks the 4th year that the Swiss Medtech Award recognises outstanding achievements in the Swiss medical…

EPFL scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will…

Co-develop the ER-004 treatment   The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment…

Additional USD 1.3 million to secure the execution of the pilot clinical trials to start early 2021   One year…

Targeting launches in the US & EU: 2021   Swiss diagnostics firm ABCDx is developing a point-of-care blood test for…

LymphoDRAIN product: advance in clinical trials & improve the usability and digitisation   LYMPHATICA Medtech, a vascular medical device development…

The new SICHH symposium series is supported by Innosuisse    The Swiss Integrative Center for Human Health (SICHH) is supported…

New opportunities in R&D and technology development   The CSL Behring Research External Innovation (REI) team in Europe & Biopôle…

The 1st COVID-19 severity score facilitating patient triage   Abionic launched a 5-minutes test for scoring COVID-19 severity. This test…

A Campus for new synergies   Consisting of three main buildings, the campus will be a training centre for health…

New private investor   Life-sciences startup SEED Biosciences raised CHF 1 million in a Series A fundraising round. The capital…